Camlin Fine Sciences Limited — Important, 24-02-2025: Agreements

Camlin Fine Sciences has entered into a Share Purchase Agreement (SPA) to acquire a majority stake in Vinpai S.A., aiming for approximately 78.68% ownership. As part of the deal, the company will invest €3.3 million in Vinpai through subscription to listed secured convertible bonds, which will later be converted into equity shares. The transaction involves a share swap with the sellers, calculated based on compliance with preferential issue pricing rules. Following the acquisition, Camlin will initiate a cash tender offer for remaining shares at €3.60 each. This strategic acquisition is expected to enhance Camlin's product offerings and market presence, leveraging Vinpai's specialization in natural ingredient solutions for the food, cosmetics, and nutraceuticals sectors. Completion of the transaction is targeted for on or before June 30, 2025, pending necessary approvals. This acquisition positions Camlin for potential growth in the burgeoning ingredient technology market. Investors should watch for developments as this acquisition unfolds.